Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	7.39e-13	114	104	12	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.04e-12	124	104	12	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	6.74e-12	137	104	12	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.54e-10	192	104	12	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 CNTNAP5 USP17L17 USP17L22 USP17L15 USP17L13	3.51e-05	654	104	13	GO:0008233
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A	1.60e-04	4	104	2	GO:0030197
GeneOntologyMolecularFunction	hyaluronic acid binding	USP17L24 SUSD5 VCAN	4.54e-04	29	104	3	GO:0005540
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.55e-12	125	104	12	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	8.41e-12	144	104	12	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	TRAF7 USP17L21 DCAF6 USP17L12 MARCHF10 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 FBXL7 USP17L17 ANKIB1 USP17L22 USP17L15 USP17L13	1.13e-05	1009	104	17	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	TRAF7 USP17L21 DCAF6 USP17L12 MARCHF10 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 FBXL7 USP17L17 ANKIB1 USP17L22 USP17L15 USP17L13	2.53e-05	1074	104	17	GO:0043687
GeneOntologyBiologicalProcess	limb development	ACD MBNL1 MECOM VPS54 ITGB4 FREM2 BMPR2	1.41e-04	224	104	7	GO:0060173
GeneOntologyBiologicalProcess	appendage development	ACD MBNL1 MECOM VPS54 ITGB4 FREM2 BMPR2	1.41e-04	224	104	7	GO:0048736
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC16 MUC5B MUC12 MUC17 VCAN MUC1 MUC3A MUC5AC MUC6	1.54e-10	109	103	10	GO:0005796
GeneOntologyCellularComponent	anchoring junction	FLNB DCAF6 DSC2 PODXL TNS2 MAST2 ITGB4 FNDC1 BMPR2 FRMD6 AMOTL1 FLRT2 GAB1 PHLDB2	3.05e-04	976	103	14	GO:0070161
GeneOntologyCellularComponent	extracellular matrix	MUC5B SMOC2 ITGB4 FREM2 MUC17 VCAN FLRT2 MUC1 MUC5AC MUC6 HCFC1	3.90e-04	656	103	11	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	MUC5B SMOC2 ITGB4 FREM2 MUC17 VCAN FLRT2 MUC1 MUC5AC MUC6 HCFC1	4.00e-04	658	103	11	GO:0030312
GeneOntologyCellularComponent	somatodendritic compartment	CACNA1F FLNB KLHL1 MYOT CLIP2 ZMYND8 ZDHHC5 AMIGO1 TAOK2 BMPR2 NF1 SIPA1L1 KCNAB1 PPP1R2P1 HCFC1	9.84e-04	1228	103	15	GO:0036477
GeneOntologyCellularComponent	dendrite	KLHL1 CLIP2 ZMYND8 ZDHHC5 AMIGO1 TAOK2 BMPR2 NF1 SIPA1L1 KCNAB1 PPP1R2P1 HCFC1	1.05e-03	858	103	12	GO:0030425
GeneOntologyCellularComponent	ankyrin-1 complex	GYPA GYPE	1.05e-03	10	103	2	GO:0170014
GeneOntologyCellularComponent	dendritic tree	KLHL1 CLIP2 ZMYND8 ZDHHC5 AMIGO1 TAOK2 BMPR2 NF1 SIPA1L1 KCNAB1 PPP1R2P1 HCFC1	1.07e-03	860	103	12	GO:0097447
Domain	HABP4_PAI-RBP1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	3.53e-22	16	103	11	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	3.53e-22	16	103	11	IPR006861
Domain	USP_CS	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	6.93e-14	66	103	11	IPR018200
Domain	USP_1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.37e-13	70	103	11	PS00972
Domain	UCH	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.62e-13	71	103	11	PF00443
Domain	USP_2	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.62e-13	71	103	11	PS00973
Domain	USP_3	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.90e-13	72	103	11	PS50235
Domain	USP_dom	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.90e-13	72	103	11	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13	1.90e-13	72	103	11	IPR001394
Domain	SEA	MUC3B MUC16 MUC12 MUC17 MUC1 MUC3A	2.27e-09	23	103	6	PS50024
Domain	SEA_dom	MUC3B MUC16 MUC12 MUC17 MUC1 MUC3A	2.27e-09	23	103	6	IPR000082
Domain	SEA	MUC3B MUC16 MUC17 MUC1 MUC3A	8.90e-09	14	103	5	SM00200
Domain	SEA	MUC3B MUC16 MUC12 MUC17 MUC1	1.13e-07	22	103	5	PF01390
Domain	TIL	MUC5B MUC5AC MUC6	3.46e-05	12	103	3	PF01826
Domain	C8	MUC5B MUC5AC MUC6	3.46e-05	12	103	3	PF08742
Domain	Unchr_dom_Cys-rich	MUC5B MUC5AC MUC6	4.48e-05	13	103	3	IPR014853
Domain	C8	MUC5B MUC5AC MUC6	4.48e-05	13	103	3	SM00832
Domain	TIL_dom	MUC5B MUC5AC MUC6	5.67e-05	14	103	3	IPR002919
Domain	-	MUC16 MUC17 MUC1	7.06e-05	15	103	3	3.30.70.960
Domain	EGF_1	MUC3B MUC12 ITGB4 CELSR1 CNTNAP5 MUC17 VCAN MUC3A	8.41e-05	255	103	8	PS00022
Domain	VWD	MUC5B MUC5AC MUC6	8.66e-05	16	103	3	SM00216
Domain	VWF_type-D	MUC5B MUC5AC MUC6	8.66e-05	16	103	3	IPR001846
Domain	VWFD	MUC5B MUC5AC MUC6	8.66e-05	16	103	3	PS51233
Domain	VWD	MUC5B MUC5AC MUC6	8.66e-05	16	103	3	PF00094
Domain	EGF_2	MUC3B MUC12 ITGB4 CELSR1 CNTNAP5 MUC17 VCAN MUC3A	1.10e-04	265	103	8	PS01186
Domain	VWC_out	MUC5B MUC5AC MUC6	1.48e-04	19	103	3	SM00215
Domain	Glycophorin	GYPA GYPE	1.79e-04	4	103	2	IPR001195
Domain	CT	MUC5B MUC5AC MUC6	2.32e-04	22	103	3	SM00041
Domain	Cys_knot_C	MUC5B MUC5AC MUC6	3.43e-04	25	103	3	IPR006207
Domain	CTCK_2	MUC5B MUC5AC MUC6	3.43e-04	25	103	3	PS01225
Domain	WxxW_domain	MUC5B MUC5AC	4.45e-04	6	103	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	4.45e-04	6	103	2	PF13330
Domain	EGF-like_CS	MUC3B MUC12 ITGB4 CELSR1 MUC17 VCAN MUC3A	6.08e-04	261	103	7	IPR013032
Domain	PHD	BAZ2B ZMYND8 PHF1 KMT2A	7.85e-04	75	103	4	PF00628
Domain	Calx_beta	ITGB4 FREM2	8.25e-04	8	103	2	SM00237
Domain	Znf_PHD-finger	BAZ2B ZMYND8 PHF1 KMT2A	9.54e-04	79	103	4	IPR019787
Domain	Calx_beta	ITGB4 FREM2	1.06e-03	9	103	2	IPR003644
Domain	Calx-beta	ITGB4 FREM2	1.06e-03	9	103	2	PF03160
Domain	Znf_FYVE_PHD	BAZ2B ZMYND8 PHF1 ANKIB1 KMT2A	1.33e-03	147	103	5	IPR011011
Domain	PHD	BAZ2B ZMYND8 PHF1 KMT2A	1.49e-03	89	103	4	SM00249
Domain	BROMODOMAIN_2	BAZ2B ZMYND8 KMT2A	1.49e-03	41	103	3	PS50014
Domain	BROMO	BAZ2B ZMYND8 KMT2A	1.60e-03	42	103	3	SM00297
Domain	Bromodomain	BAZ2B ZMYND8 KMT2A	1.60e-03	42	103	3	IPR001487
Domain	-	BAZ2B ZMYND8 KMT2A	1.60e-03	42	103	3	1.20.920.10
Domain	VWF_dom	MUC5B MUC5AC MUC6	1.60e-03	42	103	3	IPR001007
Domain	Methyl_CpG_DNA-bd	BAZ2B MBD6	1.60e-03	11	103	2	IPR001739
Domain	MBD	BAZ2B MBD6	1.60e-03	11	103	2	PF01429
Domain	DNA-bd_dom	BAZ2B MBD6	1.60e-03	11	103	2	IPR016177
Domain	MBD	BAZ2B MBD6	1.60e-03	11	103	2	SM00391
Domain	MBD	BAZ2B MBD6	1.60e-03	11	103	2	PS50982
Domain	Znf_PHD	BAZ2B ZMYND8 PHF1 KMT2A	1.61e-03	91	103	4	IPR001965
Domain	ZF_PHD_2	BAZ2B ZMYND8 PHF1 KMT2A	1.89e-03	95	103	4	PS50016
Domain	EGF_3	MUC3B CELSR1 CNTNAP5 MUC17 VCAN MUC3A	1.93e-03	235	103	6	PS50026
Domain	EGF	MUC3B CELSR1 CNTNAP5 MUC17 VCAN MUC3A	1.93e-03	235	103	6	SM00181
Domain	ZF_PHD_1	BAZ2B ZMYND8 PHF1 KMT2A	1.96e-03	96	103	4	PS01359
Domain	LINK	SUSD5 VCAN	2.26e-03	13	103	2	SM00445
Domain	Link_dom	SUSD5 VCAN	2.26e-03	13	103	2	IPR000538
Domain	Xlink	SUSD5 VCAN	2.26e-03	13	103	2	PF00193
Domain	LINK_1	SUSD5 VCAN	2.26e-03	13	103	2	PS01241
Domain	LINK_2	SUSD5 VCAN	2.26e-03	13	103	2	PS50963
Domain	EGF-like_dom	MUC3B CELSR1 CNTNAP5 MUC17 VCAN MUC3A	2.57e-03	249	103	6	IPR000742
Domain	Glyco_hormone_CN	MUC5B MUC5AC	3.02e-03	15	103	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	3.02e-03	15	103	2	PF00007
Domain	CTCK_1	MUC5B MUC5AC	4.35e-03	18	103	2	PS01185
Domain	PWWP	ZMYND8 PWWP2A	5.36e-03	20	103	2	SM00293
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	7.24e-16	45	79	11	MM15671
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	8.39e-15	16	79	8	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	1.58e-14	17	79	8	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	3.10e-13	23	79	8	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	9.74e-13	26	79	8	M27483
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 MBD6 USP17L18 USP17L17 NFRKB USP17L22 HCFC1 USP17L15 USP17L13	8.87e-11	299	79	15	M27574
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 MBD6 USP17L18 USP17L17 NFRKB USP17L22 HCFC1 USP17L15 USP17L13	1.76e-10	262	79	14	MM15286
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17 MUC1 MUC5AC MUC6	1.30e-09	21	79	6	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	1.79e-09	62	79	8	M546
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.32e-09	221	79	12	M27578
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	3.82e-09	68	79	8	M27303
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	8.58e-09	191	79	11	MM15289
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	TPR USP17L21 DCAF6 USP17L12 USP17L20 USP17L11 USP17L24 MUC16 USP17L5 MUC5B USP17L19 MUC12 MBD6 USP17L18 FBXL7 USP17L17 MUC17 VCAN NFRKB USP17L22 MUC1 MUC3A MUC5AC MUC6 HCFC1 USP17L15 USP17L13	1.23e-08	1475	79	27	M19806
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 XPO1 USP17L18 NF1 USP17L17 USP17L22 USP17L15 USP17L13	2.13e-08	318	79	13	MM15278
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC17 VCAN MUC1 MUC3A MUC5AC MUC6	9.95e-08	143	79	9	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	1.88e-07	111	79	8	M27416
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	TPR USP17L21 DCAF6 USP17L12 USP17L20 USP17L11 MUC16 USP17L5 MUC5B USP17L19 MBD6 USP17L18 FBXL7 USP17L17 MUC17 VCAN NFRKB USP17L22 MUC1 MUC5AC MUC6 HCFC1 USP17L15 USP17L13	3.14e-07	1389	79	24	MM15307
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC17 MUC1 MUC5AC MUC6	1.01e-06	60	79	6	MM15636
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	1.12e-06	140	79	8	M27484
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC16 MUC5B MUC12 MUC17 VCAN MUC1 MUC3A MUC5AC MUC6	1.05e-05	250	79	9	M27554
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC17 MUC1 MUC5AC MUC6	3.27e-05	109	79	6	MM15164
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.25e-23	21	106	11	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	8.47e-23	22	106	11	9154835
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.14e-22	33	106	12	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.75e-22	34	106	12	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.66e-22	35	106	12	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.66e-22	35	106	12	21239494
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.98e-22	24	106	11	8995226
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.98e-22	36	106	12	20147298
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	5.31e-22	25	106	11	21115691
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	5.87e-22	37	106	12	20228808
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	9.18e-22	26	106	11	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.08e-21	29	106	11	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	4.18e-18	50	106	11	31806660
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	2.43e-16	18	106	8	18834073
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B MUC5AC MUC6	1.22e-09	6	106	4	19110483
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	TET2 USP17L21 MYOT USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 GYPA GYPE USP17L22 USP17L15 USP17L13	2.23e-09	674	106	15	37196079
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	2.75e-08	3	106	3	18163520
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	2.75e-08	3	106	3	10512748
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC1 MUC5AC MUC6	2.75e-08	3	106	3	19924550
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC1 MUC5AC MUC6	2.75e-08	3	106	3	17227128
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	8.46e-08	119	106	7	28625976
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC1 MUC5AC	1.10e-07	4	106	3	25638393
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC1 MUC5AC	1.10e-07	4	106	3	22269464
Pubmed	Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	24603585
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	1.10e-07	4	106	3	23807779
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	24901817
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	36367122
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	1.10e-07	4	106	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	1.10e-07	4	106	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	1.10e-07	4	106	3	29869461
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	20929551
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC1 MUC6	1.10e-07	4	106	3	21596555
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	27298226
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	17401217
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	1.10e-07	4	106	3	12676567
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC1 MUC5AC MUC6	1.10e-07	4	106	3	25298197
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC1 MUC5AC	2.74e-07	5	106	3	11062147
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC1 MUC5AC	2.74e-07	5	106	3	16188033
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC1 MUC5AC MUC6	2.74e-07	5	106	3	16475027
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 DSC2 FAM117B MAST2 LYST BMPR2 NF1 FRMD6 STARD9 SIPA1L1 KMT2A GAB1 PHLDB2	2.29e-06	861	106	13	36931259
Pubmed	Chromatin state signatures associated with tissue-specific gene expression and enhancer activity in the embryonic limb.	FLNB MECOM ATXN2 VCAN	4.45e-06	36	106	4	22421546
Pubmed	Transcription factor foxq1 controls mucin gene expression and granule content in mouse stomach surface mucous cells.	LYST MUC1 MUC5AC	5.93e-06	12	106	3	18558092
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TET2 TCF12 BAZ2B INPP5D MBNL1 ZMYND8 XPO1 TAOK3 ATXN2 NFRKB KMT2A HADHB SAP130 HCFC1	6.73e-06	1103	106	14	34189442
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	9.20e-06	2	106	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	9.20e-06	2	106	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	9.20e-06	2	106	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	9.20e-06	2	106	2	15563276
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	9.20e-06	2	106	2	17621824
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	9.20e-06	2	106	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	9.20e-06	2	106	2	24317696
Pubmed	Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.	MUC16 MUC1	9.20e-06	2	106	2	16194893
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	9.20e-06	2	106	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	9.20e-06	2	106	2	35776514
Pubmed	Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.	MUC1 MUC5AC	9.20e-06	2	106	2	18848467
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	9.20e-06	2	106	2	24327612
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	9.20e-06	2	106	2	28321513
Pubmed	Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.	MUC16 MUC1	9.20e-06	2	106	2	30011875
Pubmed	Evolution of the human MUC1 oncoprotein.	MUC5B MUC1	9.20e-06	2	106	2	17671696
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	9.20e-06	2	106	2	28607090
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	9.20e-06	2	106	2	10973822
Pubmed	Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.	MUC16 MUC1	9.20e-06	2	106	2	25531720
Pubmed	Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.	MUC16 MUC1	9.20e-06	2	106	2	20598042
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	9.20e-06	2	106	2	31030254
Pubmed	Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.	MUC16 MUC1	9.20e-06	2	106	2	27003157
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	9.20e-06	2	106	2	23527003
Pubmed	Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.	MUC16 MUC1	9.20e-06	2	106	2	24039759
Pubmed	First case of B ALL with KMT2A-MAML2 rearrangement: a case report.	KMT2A MAML2	9.20e-06	2	106	2	28535805
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	9.20e-06	2	106	2	16540890
Pubmed	Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.	MUC1 MUC5AC	9.20e-06	2	106	2	21685325
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	9.20e-06	2	106	2	27845589
Pubmed	Molecular analysis of human glycophorin MiIX gene shows a silent segment transfer and untemplated mutation resulting from gene conversion via sequence repeats.	GYPA GYPE	9.20e-06	2	106	2	1421409
Pubmed	Quantification of MUCIN 1, cell surface associated and MUCIN16, cell surface associated proteins in tears and conjunctival epithelial cells collected from postmenopausal women.	MUC16 MUC1	9.20e-06	2	106	2	23687433
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	9.20e-06	2	106	2	27435107
Pubmed	Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.	MUC1 MUC5AC	9.20e-06	2	106	2	21815153
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	9.20e-06	2	106	2	26871672
Pubmed	Undetectable histone O-GlcNAcylation in mammalian cells.	TET2 HCFC1	9.20e-06	2	106	2	26075789
Pubmed	KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.	KMT2A MAML2	9.20e-06	2	106	2	34550633
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	9.20e-06	2	106	2	11988092
Pubmed	Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.	MUC1 MUC5AC	9.20e-06	2	106	2	20953890
Pubmed	Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.	MUC16 MUC1	9.20e-06	2	106	2	24879526
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	9.20e-06	2	106	2	11587997
Pubmed	Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.	MUC1 MUC5AC	9.20e-06	2	106	2	32776556
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	9.20e-06	2	106	2	24722639
Interaction	YWHAE interactions	TET2 DSC2 ACD TNS2 FAM117B XPO1 MBD6 MAST2 LYST TAOK2 KANK1 NF1 FRMD6 SIPA1L1 AMOTL1 KMT2A DEPDC5 MAP3K15 SAP130 GAB1 PHLDB2	8.76e-07	1256	101	21	int:YWHAE
Interaction	SAP30 interactions	TET2 MBNL1 LYST PHF1 PWWP2A KMT2A SAP130 HCFC1	1.97e-06	167	101	8	int:SAP30
Interaction	FLT3 interactions	USP17L21 USP17L12 USP17L20 USP17L11 INPP5D USP17L19 USP17L18 USP17L17 KMT2A	3.17e-05	318	101	9	int:FLT3
Interaction	BMPR1B interactions	TPRA1 DCAF6 KLHL1 BMPR2 HADHB	4.25e-05	77	101	5	int:BMPR1B
Interaction	YWHAB interactions	TET2 DSC2 TNS2 FAM117B MAST2 LYST ITGB4 KANK1 NF1 FRMD6 STARD9 SIPA1L1 KMT2A SAP130 GAB1 PHLDB2	4.27e-05	1014	101	16	int:YWHAB
Interaction	AFDN interactions	DSC2 ZDHHC5 TAOK2 FRMD6 SIPA1L1 AMOTL1 KMT2A GAB1 PHLDB2	4.54e-05	333	101	9	int:AFDN
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	5.43e-19	79	106	12	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	1.79e-13	222	106	12	chr4p16
Cytoband	7q22	MUC3B MUC12 MUC3A	9.52e-05	38	106	3	7q22
Cytoband	2q14.3	CNTNAP5 SAP130	1.08e-03	21	106	2	2q14.3
Cytoband	4q31.21	GYPA GAB1	1.66e-03	26	106	2	4q31.21
Cytoband	11p15.5	MUC5B MUC5AC MUC6	2.63e-03	118	106	3	11p15.5
GeneFamily	CD molecules\|Mucins	MUC3B MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC5AC MUC6	5.50e-17	21	74	9	648
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	TAOK2 TAOK3 MAP3K15	1.25e-04	24	74	3	654
GeneFamily	PHD finger proteins	BAZ2B ZMYND8 PHF1 KMT2A	5.06e-04	90	74	4	88
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	BAZ2B MBD6	8.87e-04	11	74	2	1025
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	3.82e-14	86	103	11	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	7.53e-13	112	103	11	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 VCAN USP17L22 USP17L15 USP17L13	1.67e-12	160	103	12	MM1155
Coexpression	NABA_ECM_AFFILIATED	MUC16 MUC5B MUC12 FREM2 MUC17 MUC1 MUC3A MUC5AC MUC6	2.44e-08	170	103	9	M5880
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 TPRA1 USP17L12 USP17L20 USP17L11 INPP5D USP17L5 USP17L19 ITGB4 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.47e-07	647	103	14	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L12 USP17L20 USP17L11 MBNL1 USP17L5 USP17L19 XPO1 USP17L18 FRMD6 USP17L17 SIPA1L1 HADHB USP17L22 POU2F3 USP17L15 USP17L13	9.21e-07	1072	103	17	MM1031
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	ZBTB38 ZMYND8 AMIGO1 PHF1 PWWP2A NFRKB C5 MAML2	1.23e-06	199	103	8	M8606
Coexpression	NABA_ECM_AFFILIATED	MUC16 MUC5B FREM2 MUC17 MUC1 MUC5AC MUC6	3.09e-06	158	103	7	MM17063
Coexpression	BRUINS_UVC_RESPONSE_LATE	TPR USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 FAM117B USP17L19 SMOC2 ITGB4 USP17L18 BMPR2 TAOK3 USP17L17 USP17L22 USP17L15 USP17L13	4.13e-06	1198	103	17	MM1062
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	FLNB TCF12 BAZ2B PODXL MBNL1 ZMYND8 MECOM XPO1 MAST2 TAOK3 FBXL7 ATXN2 SIPA1L1 FLRT2	6.57e-06	856	103	14	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 MAST2 BMPR2 NF1 SIPA1L1 DEPDC5 HCFC1	7.29e-06	180	103	7	M8239
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 TPRA1 USP17L12 USP17L20 USP17L11 INPP5D USP17L5 FAM117B USP17L19 ITGB4 RXRG USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	2.30e-05	1226	103	16	MM979
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TPR TCF12 MECOM FANCA NF1 KMT2A MAML2 MUC1	4.20e-05	323	103	8	M9150
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	ZBTB38 TCF12 KANK1 SIPA1L1 ANKIB1 MAML2	7.02e-05	176	103	6	M39223
Coexpression	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN	ZBTB38 MYOT SMOC2 KANK1 KCNAB1 POU2F3	1.17e-04	193	103	6	M8725
Coexpression	GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP	TPRA1 DSC2 PODXL MAST2 CELSR1 SIPA1L1	1.42e-04	200	103	6	M3415
Coexpression	GSE27786_LIN_NEG_VS_CD4_TCELL_DN	TET2 LYST PHF1 ANKIB1 KMT2A HADHB	1.42e-04	200	103	6	M4773
Coexpression	GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP	INPP5D MBNL1 ZMYND8 LYST FANCA TAOK3	1.42e-04	200	103	6	M7831
Coexpression	GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN	DCAF6 MBD6 AMOTL1 MAML2 RAB11FIP4 MUC1	1.42e-04	200	103	6	M9296
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	BAZ2B MECOM VPS54 LYST RPS6KC1 TAOK3 FRMD6 GAB1 PHLDB2	1.70e-04	504	103	9	M2157
Coexpression	NABA_MATRISOME	MUC16 MUC5B MUC12 SMOC2 FREM2 FNDC1 MUC17 VCAN MUC1 MUC3A MUC5AC MUC6 HCFC1	1.93e-04	1026	103	13	M5889
Coexpression	GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP	HMBOX1 KLHL1 ZMYND8 AMIGO1 FRMD6	1.97e-04	135	103	5	M447
Coexpression	NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS	MUC16 FNDC1 HCFC1	2.21e-04	30	103	3	M47990
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SMOC2 FNDC1 FBXL7 FRMD6 SUSD5 VCAN KCNAB1	2.00e-07	190	97	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	FLNB PODXL MECOM ITGB4 SIPA1L1 VCAN FLRT2	2.15e-07	192	97	7	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	TCF12 MECOM KANK1 NF1 SIPA1L1 MAML2 GAB1	2.64e-07	198	97	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MUC3A MUC5AC	2.67e-06	179	97	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MUC3A MUC5AC	2.76e-06	180	97	6	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MUC3A MUC5AC	2.76e-06	180	97	6	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB MUC16 MUC5B SYBU CELSR1 MUC5AC	2.94e-06	182	97	6	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B ITGB4 MUC17 MUC3A MUC5AC	3.03e-06	183	97	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSC2 MUC5B ADGRG4 POU2F3 MUC5AC MUC6	3.03e-06	183	97	6	263937906ddabc798bbe60f0da28ba859a5c72e2
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B ITGB4 MUC17 MUC3A MUC5AC	3.13e-06	184	97	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB MECOM TNS2 ITGB4 KANK1 FLRT2	3.33e-06	186	97	6	9c7924875f70420720149287c500b4dfa8d24673
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL SYBU LYST TAOK2 BMPR2 PHLDB2	3.33e-06	186	97	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLNB KLHL1 DSC2 LYST ITGB4 FBXL7	3.33e-06	186	97	6	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNB PODXL FBXL7 FRMD6 FLRT2 PHLDB2	3.54e-06	188	97	6	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	FLNB MECOM MUC5B ITGB4 CELSR1 MUC5AC	3.65e-06	189	97	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	PODXL MUC16 MUC5B ITGB4 MUC1 MUC5AC	3.65e-06	189	97	6	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ADGRG4 FBXL7 FRMD6 FLRT2 FRMPD3 PHLDB2	3.76e-06	190	97	6	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PODXL ITGB4 FBXL7 FRMD6 FLRT2 PHLDB2	3.76e-06	190	97	6	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 MECOM MUC5B CELSR1 MUC1 MUC5AC	3.76e-06	190	97	6	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MECOM MUC5B SYBU ITGB4 CELSR1 MUC5AC	4.00e-06	192	97	6	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	SMOC2 ADGRG4 FBXL7 FRMD6 FLRT2 PHLDB2	4.00e-06	192	97	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Control-NK_CD56bright\|Control / Disease condition and Cell class	FLNB BAZ2B LYST CELSR1 STARD9 GAB1	4.12e-06	193	97	6	8b1e7a226a6057e1097c1525984127b54e823876
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	FNDC1 FBXL7 FRMD6 SUSD5 VCAN PHLDB2	4.12e-06	193	97	6	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 FLNB BAZ2B MECOM BMPR2 FBXL7	4.24e-06	194	97	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODXL MUC16 MUC5B CELSR1 MUC1 MUC5AC	4.37e-06	195	97	6	2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODXL MUC16 MUC5B CELSR1 MUC1 MUC5AC	4.37e-06	195	97	6	576142b4e75457c0973051bccc4163bd624496af
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODXL MUC16 MUC5B CELSR1 MUC1 MUC5AC	4.37e-06	195	97	6	8f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	TCF12 MECOM KANK1 SIPA1L1 MAML2 GAB1	4.50e-06	196	97	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL INPP5D BMPR2 FBXL7 STARD9 FLRT2	4.50e-06	196	97	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	MUC16 MECOM MUC5B ITGB4 MUC1 MUC5AC	4.50e-06	196	97	6	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MARCHF10 MUC12 AMIGO1 FREM2 FAM153B MUC1	4.50e-06	196	97	6	ef650ff106a76c1e926e13c7f002fbc452cc48ae
ToppCell	(05)_Secretory\|World / shred by cell type by condition	PODXL MUC16 MUC5B SYBU MUC1 MUC5AC	4.50e-06	196	97	6	8032c25b51ef96aeba28cc52686a2bd45213453d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL INPP5D BMPR2 FBXL7 STARD9 FLRT2	4.50e-06	196	97	6	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL INPP5D BMPR2 FBXL7 STARD9 FLRT2	4.77e-06	198	97	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 DSC2 BAZ2B LYST MUC17 VCAN	4.77e-06	198	97	6	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PODXL MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.91e-06	199	97	6	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	5'-Adult\|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSC2 MUC5B MUC12 ITGB4 MUC1 MUC3A	4.91e-06	199	97	6	8b7b1fcea9a06522fdfab85d0dfd33010ae96d75
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TCF12 BAZ2B MECOM VPS54 NF1 MAML2	4.91e-06	199	97	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	PODXL MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.91e-06	199	97	6	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PODXL MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.91e-06	199	97	6	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNB BAZ2B MECOM TAOK2 BMPR2 KMT2A	5.05e-06	200	97	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / Treatment groups by lineage, cell group, cell type	FLNB KLHL1 MBNL1 ITGB4 BMPR2 FBXL7	5.05e-06	200	97	6	b036f5e22c95a3b14391785b6e91aa183b9bc9a8
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	FLNB KLHL1 TNS2 LYST ITGB4 FBXL7	5.05e-06	200	97	6	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SMOC2 ADGRG4 FBXL7 FRMD6 VCAN FLRT2	5.05e-06	200	97	6	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B CELSR1 MUC1 MUC5AC	2.57e-05	159	97	5	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	Entopeduncular\|World / BrainAtlas - Mouse McCarroll V32	BAZ2B ITGB4 KANK1 HADHB GAB1	2.64e-05	160	97	5	833763c8608de4ee6003b8fb682aa9c83d7dea9b
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLNB PODXL BMPR2 FBXL7 RP1L1	3.15e-05	166	97	5	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MECOM ITGB4 KANK1 FBXL7 KCNAB1	3.25e-05	167	97	5	f01b96173deda0239fa482989873cf308e49d48c
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MECOM ITGB4 KANK1 FBXL7 KCNAB1	3.25e-05	167	97	5	5fc85a05124cd2324e1b8ff940193880f83cd8af
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB PODXL TAOK2 KANK1 PHLDB2	3.34e-05	168	97	5	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB PODXL TAOK2 KANK1 PHLDB2	3.34e-05	168	97	5	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MECOM MUC5B MUC1 MUC5AC MUC6	3.44e-05	169	97	5	a54a8494c1feff29d77ab4737fcfabc84ace5c94
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB4 FBXL7 FRMD6 STARD9 FLRT2	3.53e-05	170	97	5	6035c92cd39c5ac54e7ec57d94888ee19f574639
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB4 FBXL7 FRMD6 STARD9 FLRT2	3.53e-05	170	97	5	c8c42eda44b61440c96b202e7f54650046eb95d3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGB4 FBXL7 FRMD6 STARD9 FLRT2	3.53e-05	170	97	5	dcc64b73134e89ae37990d4878813b86ce91dae9
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL1 INPP5D RP1L1 RAB11FIP4 POU2F3	3.53e-05	170	97	5	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC5B ITGB4 MUC5AC MUC6 PHLDB2	3.74e-05	172	97	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B FANCA CELSR1 FAM153B C5	3.95e-05	174	97	5	e2243f1e48e3275753a2b3a69d06eefce69a8ded
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	ZMYND8 KANK1 STARD9 DEPDC5 FRMPD3	4.06e-05	175	97	5	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 DCAF6 MBNL1 GFM2 MAML2	4.06e-05	175	97	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL MUC16 FREM2 KANK1 POU2F3	4.17e-05	176	97	5	8e7f38de8bf68077e2138f4d06c1f55b0fd096cc
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PODXL MUC16 FREM2 KANK1 POU2F3	4.17e-05	176	97	5	ed575330a08a6748ea4b28433292c8cfd157d444
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.40e-05	178	97	5	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.40e-05	178	97	5	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.40e-05	178	97	5	49a2271718637522f74334068d252963ee13b1ce
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC16 MUC5B ITGB4 MUC1 MUC5AC	4.40e-05	178	97	5	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	MUC16 MUC5B SYBU CELSR1 MUC5AC	4.52e-05	179	97	5	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	COVID-19_Mild-NK_CD56bright\|COVID-19_Mild / Disease condition and Cell class	FLNB BAZ2B LYST CATSPER1 GAB1	4.52e-05	179	97	5	90e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL MECOM BMPR2 AMOTL1 KMT2A	4.64e-05	180	97	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL MECOM BMPR2 AMOTL1 KMT2A	4.64e-05	180	97	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 PODXL FAM117B SYBU BMPR2	4.64e-05	180	97	5	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MECOM SMOC2 FBXL7 FRMD6 KCNAB1	4.89e-05	182	97	5	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MECOM ITGB4 KANK1 FLRT2 PHLDB2	5.02e-05	183	97	5	6f8f997ffc9eaebca2683de125b6069d07c07d26
ToppCell	facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MECOM ITGB4 KANK1 RP1L1 FLRT2	5.02e-05	183	97	5	12e876d6205af8aad74265c668b5e95b9e7487f3
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	MUC16 MUC5B SYBU CELSR1 MUC5AC	5.02e-05	183	97	5	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	IPF-Epithelial-Mesothelial\|World / Disease state, Lineage and Cell class	MUC16 SMOC2 FAM153B FLRT2 PHLDB2	5.02e-05	183	97	5	7df20e3172a1220ff427f30181f4f0c3b7fe2d42
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DSC2 PODXL MUC16 FREM2 KCNAB1	5.02e-05	183	97	5	274f274cf60daa30d6a4cd603a3af7823bfb8016
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	DSC2 ZDHHC5 LYST MUC1 POU2F3	5.15e-05	184	97	5	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC5AC MUC6	5.15e-05	184	97	5	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	SMOC2 FNDC1 FRMD6 KCNAB1 FLRT2	5.28e-05	185	97	5	506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MECOM FREM2 CELSR1 C5 MUC1	5.28e-05	185	97	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KLHL1 BAZ2B MUC16 VCAN FLRT2	5.42e-05	186	97	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	FLNB PODXL MECOM ITGB4 BMPR2	5.56e-05	187	97	5	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB MECOM TNS2 ITGB4 KANK1	5.56e-05	187	97	5	12129e02638c20d9b7c1c6e512d48bfd966e1029
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	FLNB PODXL INPP5D MECOM ITGB4	5.56e-05	187	97	5	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PODXL ZMYND8 FREM2 FBXL7 VCAN	5.56e-05	187	97	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB MECOM TNS2 ITGB4 KANK1	5.56e-05	187	97	5	83930ef55191eff9006113feaeabb3c2fa21fd05
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB PODXL MECOM ITGB4 RP1L1	5.56e-05	187	97	5	7170694a1b86fe8d84d96c880ffe57af09bdc026
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	FLNB PODXL MECOM BMPR2 FBXL7	5.56e-05	187	97	5	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SMOC2 FNDC1 FRMD6 VCAN FLRT2	5.70e-05	188	97	5	6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SMOC2 ADGRG4 FBXL7 FRMD6 FLRT2	5.70e-05	188	97	5	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HMBOX1 FBXL7 AMOTL1 MAML2 FRMPD3	5.70e-05	188	97	5	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SMOC2 FREM2 CELSR1 MUC1 MUC5AC	5.70e-05	188	97	5	3cfba3addcc9058f4ec31ad96261f79988f551a0
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	MARCHF10 MUC16 ITGB4 FREM2 MUC1	5.70e-05	188	97	5	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZMYND8 FREM2 FBXL7 VCAN MAML2	5.70e-05	188	97	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	MUC16 SMOC2 FAM153B FLRT2 PHLDB2	5.85e-05	189	97	5	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	INPP5D FAM117B LYST SIPA1L1 VCAN	5.85e-05	189	97	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SMOC2 FNDC1 KANK1 SUSD5 KCNAB1	5.85e-05	189	97	5	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DSC2 MUC5B ITGB4 CELSR1 MUC1	5.85e-05	189	97	5	ee15b4fb3a1cfda80bcf210a23f04f242594015e
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DSC2 MUC5B ITGB4 CELSR1 MUC1	5.85e-05	189	97	5	dc6f6fae84347d145bea71b49eaeeb3028e9c4ae
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	MECOM MAST2 ITGB4 FANCA FBXL7 NF1 ZNF76 FLRT2 MUC1 HCFC1	7.77e-09	194	94	10	4411_DN
Drug	Gastrin tetrapeptide	FLNB MUC3B MUC12 MUC1 MUC3A MUC5AC	5.78e-08	50	94	6	CID000005415
Drug	rioprostil	MUC3B MUC12 MUC1 MUC3A MUC5AC	1.99e-07	32	94	5	CID005311413
Drug	cellobiitol	MUC3B MUC12 MUC1 MUC3A MUC5AC	4.23e-07	37	94	5	CID000003871
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	TPRA1 ZMYND8 NF1 VCAN KCNAB1 MUC1 HCFC1 GAB1	1.55e-06	196	94	8	4196_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A	DSC2 INPP5D ZMYND8 LYST GYPA KCNAB1 FLRT2 MUC5AC	1.55e-06	196	94	8	4331_UP
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	TPRA1 DSC2 SYBU NF1 SIPA1L1 MUC1 MUC5AC HCFC1	1.55e-06	196	94	8	3324_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DSC2 TNS2 ITGB4 TAOK2 NF1 GYPA ZNF76 GAB1	1.61e-06	197	94	8	3351_UP
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	CLIP2 ZMYND8 SYBU NF1 ZNF76 MUC1 MUC6 HCFC1	1.61e-06	197	94	8	4690_UP
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A	MECOM FANCA TAOK2 PHF1 FBXL7 KCNAB1 POU2F3 GAB1	1.73e-06	199	94	8	3520_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	TPR DSC2 MBNL1 BMPR2 NF1 KMT2A ZNF76	1.35e-05	189	94	7	3788_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; PC3; HT_HG-U133A	ZMYND8 MECOM TAOK2 NF1 ZNF76 HCFC1 GAB1	1.35e-05	189	94	7	6694_UP
Drug	guanidine hydrochloride	MUC3B MUC12 VCAN MUC1 MUC3A MUC5AC	1.59e-05	129	94	6	CID000005742
Drug	Contact Lens Solutions	MUC16 MUC1	1.69e-05	2	94	2	ctd:D018639
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TPRA1 ZMYND8 MUC5B MAST2 VCAN NFRKB ZNF76	1.77e-05	197	94	7	4818_UP
Drug	Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TNS2 LYST TAOK2 NF1 GYPA C5 HCFC1	1.83e-05	198	94	7	5413_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SYBU TAOK2 BMPR2 FBXL7 NF1 NFRKB HCFC1	1.83e-05	198	94	7	1541_UP
Drug	Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A	INPP5D MUC5B TAOK2 FBXL7 GYPA KCNAB1 GAB1	1.83e-05	198	94	7	3722_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	DSC2 TNS2 SYBU LYST SIPA1L1 VCAN GAB1	1.89e-05	199	94	7	5526_UP
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	ZMYND8 MUC5B ITGB4 FBXL7 NF1 ATXN2 ZNF76	1.89e-05	199	94	7	3684_DN
Drug	Ovalbumin	FNDC1 BMPR2 C5 MUC1 MUC5AC	2.29e-05	82	94	5	ctd:D010047
Drug	heparin pentasaccharide	MUC3B MUC12 GYPE MUC1 MUC3A MUC5AC	2.97e-05	144	94	6	CID000444410
Drug	mucic acid	MUC3B MUC12 MUC1 MUC3A MUC5AC	3.22e-05	88	94	5	CID000000607
Drug	Boric Acids	MUC16 MUC1	5.05e-05	3	94	2	ctd:D001888
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	ZBTB38 BAZ2B ZMYND8 TNS2 SIPA1L1 FLRT2	7.50e-05	170	94	6	1167_UP
Drug	Tn epitope	MUC3B GYPA MUC3A POU2F3	7.91e-05	55	94	4	CID000447272
Drug	Ge 3	GYPA GYPE VCAN	8.59e-05	21	94	3	CID000444690
Drug	Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; PC3; HT_HG-U133A	DSC2 FBXL7 NFRKB KCNAB1 C5 MUC5AC	9.97e-05	179	94	6	4619_UP
Drug	Li Bo	GYPA GYPE	1.01e-04	4	94	2	CID006327674
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; HL60; HT_HG-U133A	ZBTB38 MAST2 ITGB4 TAOK2 FBXL7 SIPA1L1	1.13e-04	183	94	6	2710_UP
Drug	17-AAG; Up 200; 1uM; HL60; HT_HG-U133A	ZBTB38 CLIP2 CELSR1 NF1 MUC1 MUC6	1.13e-04	183	94	6	6166_UP
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A	FLNB BMPR2 SUSD5 SIPA1L1 VCAN FLRT2	1.30e-04	188	94	6	3046_UP
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	DSC2 MUC5B MAST2 FBXL7 NF1 VCAN	1.30e-04	188	94	6	5116_DN
Drug	Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A	DSC2 NF1 SIPA1L1 ZNF76 MUC5AC MUC6	1.34e-04	189	94	6	2300_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	TPR ZBTB38 DSC2 NF1 VCAN KMT2A	1.42e-04	191	94	6	6644_DN
Drug	Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A	ZMYND8 ITGB4 PHF1 FBXL7 VCAN ZNF76	1.42e-04	191	94	6	4247_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; PC3; HT_HG-U133A	DSC2 MUC5B ITGB4 VCAN ZNF76 C5	1.42e-04	191	94	6	1243_UP
Drug	Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A	FANCA PHF1 NF1 VCAN ZNF76 HCFC1	1.51e-04	193	94	6	3534_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ZMYND8 LYST ITGB4 SIPA1L1 VCAN KMT2A	1.51e-04	193	94	6	2209_UP
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A	TPRA1 MBNL1 TNS2 MUC5B DEPDC5 FLRT2	1.55e-04	194	94	6	7044_UP
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ZMYND8 SYBU TAOK2 ZNF76 DEPDC5 GAB1	1.55e-04	194	94	6	2789_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A	TNS2 MAST2 TAOK2 PHF1 NF1 MUC1	1.55e-04	194	94	6	4291_DN
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	TPR ZBTB38 TAOK2 PHF1 VCAN HCFC1	1.59e-04	195	94	6	7058_DN
Drug	Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	MECOM MUC5B PHF1 NF1 ZNF76 MUC1	1.59e-04	195	94	6	4781_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A	MBNL1 VPS54 MAST2 SIPA1L1 KMT2A KCNAB1	1.59e-04	195	94	6	3135_DN
Drug	Acemetacin [53164-05-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	KLHL1 INPP5D GYPA VCAN C5 GAB1	1.59e-04	195	94	6	2411_UP
Drug	5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA	ZMYND8 VPS54 ITGB4 C5 MUC1 MUC5AC	1.59e-04	195	94	6	900_UP
Drug	Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A	DSC2 ITGB4 TAOK2 KMT2A DEPDC5 MUC5AC	1.59e-04	195	94	6	6691_UP
Drug	Pindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A	NF1 KMT2A KCNAB1 DEPDC5 FLRT2 POU2F3	1.59e-04	195	94	6	6834_UP
Drug	SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A	MAST2 NFRKB KMT2A ZNF76 MUC5AC GAB1	1.59e-04	195	94	6	3272_UP
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	FLNB MAST2 LYST NF1 DEPDC5 FLRT2	1.64e-04	196	94	6	2511_DN
Drug	Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	SYBU TAOK2 FBXL7 NF1 GYPA C5	1.64e-04	196	94	6	5322_UP
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DSC2 MAST2 TAOK2 SIPA1L1 C5 GAB1	1.64e-04	196	94	6	6029_DN
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A	SYBU ITGB4 SIPA1L1 KMT2A MUC1 HCFC1	1.64e-04	196	94	6	5686_DN
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	LYST NF1 SIPA1L1 NFRKB MUC1 HCFC1	1.64e-04	196	94	6	5341_UP
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	ZMYND8 MECOM FBXL7 VCAN KCNAB1 ZNF76	1.64e-04	196	94	6	6435_UP
Drug	Ddpc	GYPA GYPE	1.67e-04	5	94	2	CID000130969
Drug	genistein; Down 200; 10uM; PC3; HT_HG-U133A	ZMYND8 MAST2 ITGB4 NF1 ZNF76 DEPDC5	1.68e-04	197	94	6	4459_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	ZMYND8 TAOK2 NF1 KCNAB1 MUC1 MUC5AC	1.68e-04	197	94	6	5057_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	DSC2 FANCA KMT2A KCNAB1 MUC1 HCFC1	1.68e-04	197	94	6	3484_UP
Drug	Napelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A	FLNB INPP5D ZMYND8 VPS54 LYST NFRKB	1.68e-04	197	94	6	2522_DN
Drug	Chlormezanone [80-77-3]; Up 200; 14.6uM; PC3; HT_HG-U133A	ITGB4 VCAN NFRKB DEPDC5 MUC6 GAB1	1.68e-04	197	94	6	4636_UP
Drug	Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A	FLNB VPS54 LYST NF1 VCAN KCNAB1	1.68e-04	197	94	6	3070_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A	ZMYND8 TAOK2 BMPR2 ZNF76 C5 HCFC1	1.68e-04	197	94	6	2169_DN
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ZMYND8 VPS54 CELSR1 NF1 NFRKB MUC1	1.68e-04	197	94	6	6233_UP
Drug	Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A	MUC5B SYBU NF1 ZNF76 POU2F3 MUC5AC	1.68e-04	197	94	6	3388_UP
Drug	Iopromide [73334-07-3]; Down 200; 5uM; PC3; HT_HG-U133A	DSC2 ZMYND8 FBXL7 NF1 ZNF76 GAB1	1.68e-04	197	94	6	4504_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	DSC2 TAOK2 SIPA1L1 KMT2A HCFC1 GAB1	1.68e-04	197	94	6	3865_DN
Drug	Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A	LYST TAOK2 PHF1 SIPA1L1 MUC1 GAB1	1.68e-04	197	94	6	2826_UP
Drug	3,5-diaminocyclohexan-1-ol	NF1 GYPA GYPE VCAN	1.71e-04	67	94	4	CID004632239
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A	TPRA1 ITGB4 NF1 ZNF76 DEPDC5 HCFC1	1.73e-04	198	94	6	3895_DN
Drug	Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A	FANCA TAOK2 NF1 VCAN ZNF76 MUC1	1.73e-04	198	94	6	3700_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; HL60; HT_HG-U133A	FLNB ZMYND8 ITGB4 BMPR2 GYPA C5	1.73e-04	198	94	6	2159_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	TNS2 SYBU FANCA NF1 SUSD5 MUC1	1.73e-04	198	94	6	3521_UP
Drug	Etomidate [33125-97-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	TNS2 MAST2 TAOK2 KCNAB1 ZNF76 HCFC1	1.73e-04	198	94	6	3519_UP
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; HL60; HT_HG-U133A	ITGB4 NF1 VCAN NFRKB C5 FLRT2	1.73e-04	198	94	6	2538_DN
Drug	Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A	TNS2 LYST ITGB4 NF1 KCNAB1 HCFC1	1.73e-04	198	94	6	3548_UP
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A	FANCA FBXL7 NFRKB KMT2A ZNF76 HCFC1	1.73e-04	198	94	6	5387_UP
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	TPR ZMYND8 TAOK2 VCAN KCNAB1 ZNF76	1.78e-04	199	94	6	4316_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A	BAZ2B ITGB4 FANCA TAOK2 BMPR2 KMT2A	1.78e-04	199	94	6	7284_DN
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; HL60; HT_HG-U133A	TNS2 BMPR2 SIPA1L1 VCAN C5 FLRT2	1.78e-04	199	94	6	2533_DN
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAST2 FANCA FBXL7 NF1 KMT2A KCNAB1	1.78e-04	199	94	6	2243_DN
Drug	estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	TAOK2 NF1 ZNF76 DEPDC5 MUC1 GAB1	1.78e-04	199	94	6	5960_DN
Drug	Tropine [120-29-6]; Up 200; 28.4uM; MCF7; HT_HG-U133A	PODXL ZMYND8 MAST2 NF1 KCNAB1 MUC6	1.78e-04	199	94	6	3569_UP
Drug	Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; MCF7; HT_HG-U133A	DSC2 LYST TAOK2 FBXL7 KCNAB1 ZNF76	1.78e-04	199	94	6	1500_UP
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A	CLIP2 ITGB4 NF1 ZNF76 MUC1 GAB1	1.78e-04	199	94	6	3128_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	FANCA TAOK2 CELSR1 VCAN KMT2A ZNF76	1.78e-04	199	94	6	2320_UP
Drug	Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A	ITGB4 BMPR2 SIPA1L1 VCAN KCNAB1 ZNF76	1.83e-04	200	94	6	3036_DN
Drug	inulin	MUC3B MUC12 MUC1 MUC3A MUC5AC	2.28e-04	133	94	5	CID000024763
Drug	Berol	GYPA GYPE	2.50e-04	6	94	2	CID000069182
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 KMT2A USP17L22 SAP130 HCFC1 USP17L15 USP17L13	3.17e-23	69	105	15	DOID:1682 (implicated_via_orthology)
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13	7.58e-20	46	105	12	DOID:5426 (implicated_via_orthology)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC1 MUC3A MUC5AC MUC6	1.11e-07	64	105	6	DOID:4947 (is_marker_for)
Disease	cortical surface area measurement	TET2 FLNB BAZ2B PODXL MECOM FAM117B SYBU XPO1 SMOC2 MBD6 MAST2 CELSR1 FBXL7 ATXN2 GYPA GYPE VCAN RP1L1 RAB11FIP4	2.54e-07	1345	105	19	EFO_0010736
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC1 MUC5AC	5.16e-06	10	105	3	DOID:10140 (is_marker_for)
Disease	wellbeing measurement	KLHL1 MARCHF10 BAZ2B MBNL1 ZMYND8 ZDHHC5 VPS54 TAOK3 CNTNAP5 ATXN2 RP1L1 KMT2A	6.72e-06	692	105	12	EFO_0007869
Disease	smoking status measurement, chronic obstructive pulmonary disease	TET2 ZBTB38 MECOM GYPA GYPE	1.61e-05	88	105	5	EFO_0000341, EFO_0006527
Disease	pancreatic cancer (is_marker_for)	MUC16 XPO1 MUC1 MUC5AC MUC6	3.13e-05	101	105	5	DOID:1793 (is_marker_for)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	3.75e-05	3	105	2	DOID:9368 (is_marker_for)
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC3A MUC5AC	6.76e-05	61	105	4	DOID:3587 (is_marker_for)
Disease	cystic fibrosis (is_marker_for)	MUC5B C5 MUC1 MUC5AC	7.21e-05	62	105	4	DOID:1485 (is_marker_for)
Disease	dry eye syndrome (is_implicated_in)	MUC1 MUC5AC	7.49e-05	4	105	2	DOID:10140 (is_implicated_in)
Disease	asthma (is_marker_for)	MUC5B BMPR2 C5 MUC1 MUC5AC	9.00e-05	126	105	5	DOID:2841 (is_marker_for)
Disease	response to bronchodilator, FEV/FEC ratio	TET2 SMOC2 LYST CNTNAP5 KANK1 FBXL7 GYPA GYPE SIPA1L1 RP1L1 FLRT2	9.14e-05	766	105	11	EFO_0004713, GO_0097366
Disease	neutrophil count	TET2 FLNB INPP5D MBNL1 MECOM XPO1 MAST2 FANCA GABPB2 ATXN2 GYPA GYPE RP1L1 PPP1R2P1 POC5	1.12e-04	1382	105	15	EFO_0004833
Disease	Nephrotic Syndrome	PODXL TNS2 KANK1	1.20e-04	27	105	3	C0027726
Disease	mucinous adenocarcinoma (is_marker_for)	MUC5AC MUC6	1.25e-04	5	105	2	DOID:3030 (is_marker_for)
Disease	diabetic neuropathy	GYPA GYPE	1.25e-04	5	105	2	EFO_1000783
Disease	depressive symptom measurement	MARCHF10 MBNL1 ZMYND8 ZDHHC5 VPS54 PHF1 TAOK3 KMT2A	1.45e-04	426	105	8	EFO_0007006
Disease	hemorrhoid	TET2 MUC12 FBXL7 NF1 PHLDB2	1.85e-04	147	105	5	EFO_0009552
Disease	nasopharyngeal neoplasm	MECOM FBXL7 KMT2A C5 GAB1	2.10e-04	151	105	5	EFO_0004252
Disease	peptic ulcer disease	MECOM MUC1 MUC6	2.21e-04	33	105	3	MONDO_0004247
Disease	acute myeloid leukemia (is_implicated_in)	TET2 FANCA NF1 KMT2A	2.35e-04	84	105	4	DOID:9119 (is_implicated_in)
Disease	pack-years measurement, systolic blood pressure	MECOM GYPA GYPE	2.42e-04	34	105	3	EFO_0006335, EFO_0006526
Disease	monocyte count	TET2 FLNB BAZ2B INPP5D MECOM XPO1 MAST2 LYST FANCA NF1 ATXN2 GYPA GYPE VCAN	2.45e-04	1320	105	14	EFO_0005091
Disease	pulmonary function measurement, forced expiratory volume	TET2 ZBTB38 MECOM	3.12e-04	37	105	3	EFO_0003892, EFO_0004314
Disease	common bile duct neoplasm (is_marker_for)	MUC1 MUC5AC	3.46e-04	8	105	2	DOID:4608 (is_marker_for)
Disease	Lymphoid leukemia	MECOM KMT2A	3.46e-04	8	105	2	C0023448
Disease	Leukemia, Myelocytic, Acute	TET2 MECOM FANCA NF1 KMT2A	3.93e-04	173	105	5	C0023467
Disease	neuroticism measurement	MARCHF10 INPP5D MBNL1 ZMYND8 ZDHHC5 VPS54 PHF1 TAOK3 SIPA1L1 RP1L1 KMT2A	3.99e-04	909	105	11	EFO_0007660
Disease	chronic obstructive pulmonary disease (is_marker_for)	MUC5B C5 MUC1 MUC5AC	4.07e-04	97	105	4	DOID:3083 (is_marker_for)
Disease	peak expiratory flow	TET2 ZBTB38 PODXL CATSPER1 GYPA GYPE ZNF76 PHLDB2	4.15e-04	498	105	8	EFO_0009718
Disease	heart rate response to exercise	MUC3B RP1L1 MUC3A	4.87e-04	43	105	3	EFO_0009184
Disease	ornithine measurement	MECOM GYPA GYPE	5.22e-04	44	105	3	EFO_0009776
Disease	hemoglobin A1 measurement	TET2 ZBTB38 MBNL1 MAST2 TAOK3 GYPE RP1L1 MAP3K15	5.52e-04	520	105	8	EFO_0007629
Disease	allergic rhinitis (biomarker_via_orthology)	MUC1 MUC5AC	5.54e-04	10	105	2	DOID:4481 (biomarker_via_orthology)
Disease	Malignant neoplasm of salivary gland	ITGB4 FANCA VCAN	5.57e-04	45	105	3	C0220636
Disease	sexual dimorphism measurement	TET2 ZBTB38 PODXL SMOC2 TAOK2 CATSPER1 NF1 GYPA GYPE POC5 RAB11FIP4 MUC1	5.73e-04	1106	105	12	EFO_0021796
Disease	cortical thickness	FLNB MECOM SYBU SMOC2 MBD6 MAST2 CELSR1 FBXL7 ATXN2 VCAN KMT2A RAB11FIP4	6.06e-04	1113	105	12	EFO_0004840
Disease	cryptic phenotype measurement	ATXN2 GYPA GYPE	6.34e-04	47	105	3	EFO_0021487
Disease	Salivary Gland Neoplasms	ITGB4 FANCA VCAN	6.34e-04	47	105	3	C0036095
Disease	chronic bronchitis	GYPA GYPE	6.76e-04	11	105	2	EFO_0006505
Disease	pulmonary fibrosis	MUC5B MUC5AC	6.76e-04	11	105	2	EFO_0009448
Disease	taurodeoxycholate measurement	MBNL1 SMOC2	8.09e-04	12	105	2	EFO_0010539
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	TET2 MECOM ATXN2	8.52e-04	52	105	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	apolipoprotein A 1 measurement	TET2 ZBTB38 MBNL1 TAOK2 BMPR2 ATXN2 MUC17 KMT2A RAB11FIP4 MUC1	9.00e-04	848	105	10	EFO_0004614
Disease	leukemia	FANCA NF1 KMT2A	1.00e-03	55	105	3	C0023418
Disease	mean platelet volume	TET2 ZBTB38 TCF12 ZMYND8 MECOM SMOC2 FANCA PWWP2A ATXN2 MAML2 HADHB	1.03e-03	1020	105	11	EFO_0004584
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.11e-03	14	105	2	DOID:10808 (implicated_via_orthology)
Disease	cardiac troponin T measurement	INPP5D MECOM CELSR1 NF1 RAB11FIP4	1.14e-03	219	105	5	EFO_0005043
Disease	preeclampsia, hypertension, pregnancy-induced	MECOM TNS2	1.46e-03	16	105	2	EFO_0000668, MONDO_0024664
Disease	central nervous system disease (implicated_via_orthology)	TAOK2 TAOK3	1.46e-03	16	105	2	DOID:331 (implicated_via_orthology)
Disease	asthma	ZBTB38 MUC16 MECOM ATXN2 GYPA GYPE ZNF76 MUC5AC GAB1	1.46e-03	751	105	9	MONDO_0004979
Disease	vital capacity	TET2 ZBTB38 PODXL MBNL1 MECOM GABPB2 SUSD5 GYPA GYPE FLRT2 MUC1 GAB1	1.49e-03	1236	105	12	EFO_0004312
Disease	susceptibility to cold sores measurement	MUC16 GYPA GYPE	1.63e-03	65	105	3	EFO_0008402
Disease	plasma protease C1 inhibitor measurement	ZDHHC5 ATXN2	1.65e-03	17	105	2	EFO_0008261
Disease	otitis media (biomarker_via_orthology)	MUC1 MUC5AC	1.65e-03	17	105	2	DOID:10754 (biomarker_via_orthology)
Disease	MYELODYSPLASTIC SYNDROME	TET2 MECOM FANCA	1.78e-03	67	105	3	C3463824
Disease	kidney volume	GYPA GYPE	1.85e-03	18	105	2	EFO_0600044
Disease	parahippocampal gyrus volume measurement	ZMYND8 FREM2	1.85e-03	18	105	2	EFO_0010318
Disease	Myeloid Leukemia	MECOM KMT2A	1.85e-03	18	105	2	C0023470
Disease	Leukemia, Monocytic, Chronic	MECOM KMT2A	1.85e-03	18	105	2	C0023466
Disease	peritonsillar abscess	TET2 KLHL1	1.85e-03	18	105	2	EFO_0007429
Disease	emphysema pattern measurement	GYPA GYPE	2.06e-03	19	105	2	EFO_0005850
Disease	anorectal malformation	MUC5B SUSD5	2.06e-03	19	105	2	MONDO_0019938
Disease	blood aluminium measurement	ZBTB38 BAZ2B	2.29e-03	20	105	2	EFO_0007575
Disease	citrulline measurement	MECOM RP1L1	2.29e-03	20	105	2	EFO_0009777
Disease	glucose measurement	TET2 ZBTB38 MBNL1 MECOM ATXN2 MAP3K15	2.42e-03	380	105	6	EFO_0004468
Disease	apolipoprotein B measurement	HMBOX1 TCF12 FAM117B AMIGO1 NF1 ATXN2 POC5 MUC1	2.57e-03	663	105	8	EFO_0004615
Disease	sudden cardiac arrest	MARCHF10 BAZ2B MAML2	3.27e-03	83	105	3	EFO_0004278
Disease	Sjogren's syndrome (is_marker_for)	MUC16 MUC5AC	3.29e-03	24	105	2	DOID:12894 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PSSHQGDSLSSSMLS	AMIGO1	406	Q86WK6
GDSLSSSMLSTTPNH	AMIGO1	411	Q86WK6
PRGSAHSMTRSSSTI	CATSPER1	356	Q8NEC5
SHISDSEGPSSTMVS	VCAN	1981	P13611
MTDTGFPETTKISSH	ADGRG4	1296	Q8IZF6
TSSVKSPSMSLTGHS	BAZ2B	676	Q9UIF8
GTSVVSSASMSVLHS	ANKIB1	811	Q9P2G1
MSSQTSSASGPLHSV	AMOTL1	391	Q8IY63
MGVSALTHSPSSSSI	CLIP2	306	Q9UDT6
DHGSPPMSSSTSVSI	CELSR1	661	Q9NYQ6
TMSAQAHSTSSPTES	DCAF6	416	Q58WW2
ASSHEQTTSHSMGSP	FLRT2	526	O43155
SMHPTTGVITTTSSQ	DSC2	296	Q02487
LPAVSEFSTSETMGH	HADHB	211	P55084
TMSTATPSSTPETVH	MUC5B	2561	Q9HC84
TMSTATPSSTPETVH	MUC5B	3261	Q9HC84
TMSTATPSSTPETVH	MUC5B	4546	Q9HC84
VHTPSMTTSDLSTHS	RAB11FIP4	191	Q86YS3
MSGTATSSPHSELES	MECOM	996	Q03112
SHASLPASDTGSMTE	CACNA1F	466	O60840
QMTGPISTHSLESTA	DEPDC5	1016	O75140
THETGTTNTATTAMS	HCFC1	1111	P51610
PCETHQTTSTGTTMS	HCFC1	1356	P51610
ETGTTHTATTVTSNM	HCFC1	1426	P51610
HLPIGTTASSETSMD	MUC16	1056	Q8WXI7
SPGTISTMHTTSFLA	MUC16	3606	Q8WXI7
SSTELDSMSTPHGRI	MUC16	3621	Q8WXI7
THMTTTQTGSSGATS	MUC16	4676	Q8WXI7
STSMPVHGSSETTNI	MUC16	5166	Q8WXI7
TSSRTTISGPDHSKM	MUC16	5821	Q8WXI7
PTTSSRAGTHSMATQ	MUC16	6756	Q8WXI7
FSHSEMTTLVSRSPG	MUC16	8236	Q8WXI7
IHPSSSMAVTNVGTT	MUC16	10096	Q8WXI7
KSDTTPSMTTSHGAE	MUC16	10846	Q8WXI7
PSMTTSHGAESSSAV	MUC16	10851	Q8WXI7
TPSMATSHGEEASSA	MUC16	10906	Q8WXI7
TTPSMATSHGTEAGS	MUC16	10961	Q8WXI7
TPSMATSHGAEASST	MUC16	11016	Q8WXI7
ELETTPSMATSHGAE	MUC16	11066	Q8WXI7
PSMATSHGAEASSAV	MUC16	11071	Q8WXI7
TPSMATSHGVEASSA	MUC16	11126	Q8WXI7
ATGSTHTAPTMTLTT	MUC6	1661	Q6W4X9
HTAPTMTLTTSGTSQ	MUC6	1666	Q6W4X9
QMATSASIHSTPTGT	MUC6	2031	Q6W4X9
GASATAVPSAASMTS	POC5	426	Q8NA72
PETMSSSPTAASTTH	PODXL	311	O00592
PTLCTSSMAGDASSH	FAM189A1	401	O60320
SMETTCSHSSPGEGA	MBD6	116	Q96DN6
SGTVHTSAVSLPSMN	NFRKB	1121	Q6P4R8
VDHSSSGDMSLLPSS	RPS6KC1	781	Q96S38
MSPRPDSVHSTTSSS	GAB1	566	Q13480
TTSSMVASAEHPRGS	PPP1R2P1	21	Q96PQ5
DLSSEHTTVCTTGMP	KCNAB1	76	Q14722
SGSMPSRSTSHTSDF	ATXN2	521	Q99700
ASFTSSVIMSADHPG	FREM2	2761	Q5SZK8
MTSSVLSSHSPGSGS	MUC1	56	P15941
ATASTQTQHSGMSPS	HMBOX1	86	Q6NT76
SSDMSAHVTSPSGRV	FLNB	2126	O75369
MSASSAGTTHTETIS	MUC3A	1291	Q02505
SMSASSVGTTHTQSI	MUC3A	1666	Q02505
TSEMPSHSTPSFTSS	MUC3A	2116	Q02505
GILGTSTSHMSQSSS	TCF12	251	Q99081
SISASSTTGVAMHTS	GYPE	16	P15421
TTSSMGSSIRHSPLS	KANK1	231	Q14678
TTHMPSASTEQPTAT	MUC5AC	1706	P98088
TTFTTHMPSASTEQP	MUC5AC	2076	P98088
MTTTSAAAYGTHLSP	ITGB4	1461	P16144
VHSTMPGTVTSSCSP	POU2F3	371	Q9UKI9
TSHGTRMPSLSTAVQ	MAML2	851	Q8IZL2
SMTSHGSSHTSGVES	FRMD6	426	Q96NE9
SSSSITGETVAMVHS	FBXL7	76	Q9UJT9
SPTSATVMSTFTHSL	FRMPD3	1791	Q5JV73
NAPSRSTMSSSVSSH	FNDC1	756	Q4ZHG4
GSGHSLTVTTGMTTT	FAM117B	531	Q6P1L5
MGLLSSHLTSNSTTD	FANCA	1266	O15360
SSGSSHAVMDISLPT	C5	1416	P01031
SISASSTTGVAMHTS	GYPA	16	P02724
ISSEHSMSSTPLTIG	BMPR2	566	Q13873
TSGYDSTASEPLSHM	LYST	926	Q99698
MVHGATPATVSAATT	MBNL1	341	Q9NR56
PVDLSMSSTSVHSSD	MARCHF10	486	Q8NA82
SESSHTESDSSPPMT	MAST2	911	Q6P0Q8
SSTVKHSTSSIGSML	KMT2A	996	Q03164
RSPMSTNSSVHTGSD	ZMYND8	431	Q9ULU4
MAFSSSSDLTGTHSP	CNTNAP5	41	Q8WYK1
STITGSHQQMSASPS	FAM153B	326	P0C7A2
TMPVVSSEASTHSTT	MUC17	2406	Q685J3
EAHSSPTTSEGTSMP	MUC17	3141	Q685J3
GSMDSSTSTLHTLTP	MUC3B	516	Q9H195
HSMTASSSSVSSPSP	PHF1	491	O43189
MATSSSEHGSVSPDS	MAP3K15	941	Q6ZN16
SAGTTEPHTRVSMAT	GABPB2	431	Q8TAK5
MHAPSTSSTSSSSKE	PWWP2A	611	Q96N64
KSSTLTPSEGMTHSS	SUSD5	421	O60279
TLHSLTIHPGTSTTM	GFM2	651	Q969S9
LSHSASFSSPMGSTE	SIPA1L1	376	O43166
SHTSTMSSRHSASPV	SIPA1L1	1421	O43166
GSTSDIMTSDHSPVF	INPP5D	691	Q92835
SHSVPSMSISASSQS	TAOK2	351	Q9UL54
SNHSIPSMSVSTGSQ	TAOK3	346	Q9H2K8
VSPAHTSYSETMSTL	STARD9	361	Q9P2P6
SSISPHFSSATMGRS	PHLDB2	906	Q86SQ0
LPGHMSSEESGTSIS	ACD	281	Q96AP0
ASMPCHTGSINSTDS	TPRA1	351	Q86W33
TDTSHTAGLTMHASI	XPO1	931	O14980
SHAMTENFTPTSSSG	RP1L1	1186	Q8IWN7
SSSTGSISAPEVHMS	SYBU	151	Q9NX95
HASQSVPMVTTSTGT	TPR	2236	P12270
STDMVHAASDPSSSS	SMOC2	321	Q9H3U7
STIVTMTVPSHSSHA	SAP130	406	Q9H0E3
MTVPSHSSHATAVTT	SAP130	411	Q9H0E3
STTPTHQESMNTGTL	USP17L18	491	D6R9N7
SSTPTHQESMNTGTL	USP17L5	491	A8MUK1
HSESSMSLRSTFSLP	TRAF7	96	Q6Q0C0
SSTPTHQESMNTGTL	USP17L21	491	D6R901
SSTPTHQESMNTGTL	USP17L13	491	C9JLJ4
SMTSLATSQHSPGID	NF1	2781	P21359
HTGSTSMSPSAALST	RXRG	21	P48443
STTPTHQESMNTGTL	USP17L19	491	D6RCP7
STTPTHQESMNTGTL	USP17L12	491	C9JPN9
SSTSAAMPHSSSAKL	ZDHHC5	361	Q9C0B5
SSTPTHQESMNTGTL	USP17L24	491	Q0WX57
EFSSTGSTLPDTDHM	ZBTB38	436	Q8NAP3
STTPTHQESMNTGTL	USP17L22	491	D6RA61
NSSHTSDIYGSTSPM	TET2	1581	Q6N021
STTPTHQESMNTGTL	USP17L15	491	C9J2P7
SSTPTHQESMNTGTL	USP17L17	491	D6RBQ6
HPTSCSSSSEIMSVL	TKTL1	46	P51854
MLSVSSDSGHSSTLT	TNS2	506	Q63HR2
SAISMVTQHGSTTLT	ZNF76	456	P36508
ADLATSGTHTVTMVS	ZNF76	476	P36508
STTPTHQESMNTGTL	USP17L20	491	D6RJB6
MASSHSSSPVPQGSS	VPS54	1	Q9P1Q0
STTPTHQESMNTGTL	USP17L11	491	C9JVI0
GHSMTPQSDLDSSSS	KLHL1	171	Q9NR64
STTMPGVSQESTASH	MUC12	326	Q9UKN1
TQTMHFPESSTTSGH	MUC12	511	Q9UKN1
ESTAYHSSPGSTQTM	MUC12	1911	Q9UKN1
STQTMHFPESSTASG	MUC12	1921	Q9UKN1
TMPGVSQESTASHSS	MUC12	3296	Q9UKN1
SEESTTSHSRPGSMH	MUC12	4356	Q9UKN1
STQTMHFPESNTTSG	MUC12	4561	Q9UKN1
SPGSTQTMHFPESST	MUC12	4751	Q9UKN1
STLSSHITMSSSAFP	MYOT	56	Q9UBF9